Encapsidation of papillomavirus DNA involves DNA-protein and protein-protein interactions. We sought to define the role of each human papillomavirus (HPV) capsid protein in HPV DNA encapsidation. HPV16 major (Li) and minor (L2) capsid proteins purified from recombinant vaccinia virus-infected cells were compared for their ability to bind nucleic acids. L2 protein, but not LI protein, could bind HPV DNA. To map the DNA-binding region of L2, a series of truncated or point-mutated L2 protein open reading frames were used to show that only the N terminal of L2 was required for L2-DNA binding. This interaction depends critically on charged amino acids (Lys or Arg) in the first 12 amino acids of the N terminal of the protein. Several techniques were used to show that L2 interaction with DNA did not require specific DNA sequences. We propose that HPV L2 protein may play a major role in papillomavirus capsid assembly by introducing HPV DNA to the virus particles formed by the self assembly of the LI major structural protein.
their ability to bind nucleic acids. L2 protein, but not LI protein, could bind HPV DNA. To map the DNA-binding region of L2, a series of truncated or point-mutated L2 protein open reading frames were used to show that only the N terminal of L2 was required for L2-DNA binding. This interaction depends critically on charged amino acids (Lys or Arg) in the first 12 amino acids of the N terminal of the protein. Several techniques were used to show that L2 interaction with DNA did not require specific DNA sequences. We propose that HPV L2 protein may play a major role in papillomavirus capsid assembly by introducing HPV DNA to the virus particles formed by the self assembly of the LI major structural protein.
Human papillomaviruses (HPVs) are a family of small DNA viruses which induce benign hyperproliferative lesions of the cutaneous and mucosal epithelia. Of the 70 different virus types which have been identified, more than 20 are associated with anogenital lesions (9) . Regulatory signals for HPV DNA replication and for transcription have been analyzed in great detail (4, 6) . However, studies on papillomavirus (PV) virion assembly and PV DNA encapsidation are limited because no tissue culture system readily supports PV propagation and because lesions associated with infection with HPV16, the major genotype associated with anogenital malignancy (40) , contain few PV particles and low levels of viral structural proteins.
PV capsids comprise two virally encoded structural proteins, designated LI and L2, which are assembled onto a DNAprotein complex (13) . A single virus capsid is a T=7d icosahedron composed of 72 pentameric capsomeres, each of which contains five molecules of the major capsid protein, LI (1, 12) . The minor capsid protein, L2, is present at approximately 1/10 the abundance of LI (10) and has an unknown structural role. LI protein is directed to the nucleus by a C-terminal nuclear localization signal (36) ; virus assembly occurs in the nucleus (28, 29) . Recombinant LI protein self-assembles into particles resembling virus capsids (37) , but assembly is enhanced in the presence of L2 protein, which may be required for assembly of infectious virions (15, 39) .
As a step toward the definition of the mechanism of PV assembly and of encapsidation of the viral minichromosome, we characterized the interaction of each of the capsid proteins of HPV16 with nucleic acid by using purified LI and L2 proteins expressed from recombinant vaccinia viruses (rVV).
MATERIALS AND METHODS
Plasmid construction. For expression in VV, the open reading frame corresponding to the 474-amino-acid HPV16L2 coding region was amplified by PCR from a plasmid containing the HPV16 genome. The 5' primer introduced a BamHI site upstream from the L2 open reading frame ATG, and the 3' primer introduced a SmaI site beyond the termination codon. The amplified L2 fragment was recovered by elution from an agarose gel, cut with BamHI and Smal, and ligated into plasmid RK19 (16) , creating RK19/16L2, in which L2 expression is driven by the VV late promoter 4b. The HPV16L2 and 4b promoter were then transferred to the VV expression vector pSX3 (39) for rVV construction.
To create the simplified vector pUCI8/4bl6L2 and facilitate transfer of mutant L2 genes between vectors used for VV expression, a Klenow-blunted MluI-EcoRI fragment carrying the VV 4b promoter and the whole HPV16L2 open reading frame was cleaved from RK19/16L2 and inserted into pUC18. This plasmid was used as the DNA template for PCR amplifications with primers designed to create C-terminal truncations of L2. Mutants A374, A384, A394, A404, and A414, C-terminally truncated to residues 374, 384, 394, 404, and 414 of the L2 protein, respectively, were created by using a common 5' primer (M13RSP) (36) 18 cycles of PCR in the presence of 32P-labeled nucleotide, as described previously (33) . DNA from the fifth round of selection which remained bound to L2 after washing in buffer A was eluted and amplified as described above, cloned into pUC18, and sequenced. (Fig. 1B, lanes 2 to 5) . HPV16L1 protein, in contrast, failed to bind any labeled DNA (Fig. 1A, lanes 2 to 5) , although the purified LI protein was detectable on the filters by using an anti-HPV16L1 monoclonal antibody (Fig. 1A lanes 1 and 6) from amino acids 1 to 12; the second lies within the C terminus (RKRRKR) from amino acids 456 to 461.
To determine whether either charged region was involved in DNA binding to L2, we made a series of deletion mutants with mutations in HPV16L2. Constructs encoding various C-terminal or N-terminal mutations of HPV16L2 protein were inserted into plasmid pSX3, which had been previously shown to efficiently direct the synthesis of the HPV16L1 proteins in rVVs (36) . CV-1 cells were infected with rVV containing each mutant L2 gene, and cell lysate was analyzed by immunoprecipitation with a rabbit anti-HPV16L2 antibody. The expected relative size of each mutated protein was confirmed by comparing the electrophoretic mobility of truncated proteins with wild-type L2 protein (data not shown).
The deletion mutants were examined for binding to 32p-labeled HPV16 genomic DNA by the Southwestern procedure under conditions associated with binding of native L2 protein. All C-terminal deletion mutants tested, including A374, which had the longest deletion, bound HPV DNA in proportion to the amount of immunoreactive L2 protein present (Fig. 2, lane  A374) . To delineate the contribution of the N terminus of L2 to DNA binding, we constructed N-terminal deletion mutants of L2. Three mutants, in which the first 60, 80, and 100 amino acids of L2 were deleted, each failed to bind HPV DNA (Fig.  2, lanes A1-60 through A1-100) . To further characterize the N-terminal DNA-binding region, we tested a series of smaller deletions between amino acids 1 and 15 for their DNA-binding activity. Each of these, including the smallest deletion (which was missing only the arginine residue at position 2), failed to bind DNA (Fig. 3A , lanes A1-2 to Al-15). These results suggested that critical DNA-binding sequences were in the N terminus of L2 and that binding was dependent on charged amino acids including the arginine at position 2.
L2 protein uses an arginine-rich motif for DNA binding. The amino acid sequence of the N terminus of HPV16L2, starting from position 1, is MRHKRSAKRTKR (one-letter code with charged amino acids underlined). (Fig. 3B, lower panel) . Mutation of some charged amino acid residues (Lys-4, Lys-8, Arg-9) to Pro or Asn (K4P and 8,9N) abolished DNA binding (Fig. 3B, lanes K4P and 8,9N ), while substitution of Arg-5 with Pro (R5P) reduced binding activity (lane R5P). In contrast, substitution of Arg-9 with Pro (R9P) had no effect on DNA binding (lane R9P). Mutation of the neutral amino acids between the Lys-Arg clusters had less effect on DNA-binding activity. Mutations termed H3P, S6P, and A7P, in which substitution of His-3, Ser-6, and Ala-7 for Pro had been produced, showed binding of DNA comparable to that with wild-type L2 (lanes H3P, S6P, and A7P); in contrast, changing Ser-6 to Asn (S6N) abolished DNA binding (lane S6N). These results suggest that the four charged amino acid clusters are important for DNA binding. In each of these charged amino acid clusters, retention of at least one charged amino acid appears necessary for DNA binding. A flexible secondary structure might also be important for L2-DNA interaction because substitution of Ser-6 with Pro and of Arg-5 and Arg-9 did not abolish the DNA binding, whereas the substitution of Ser-6 with Asn removed the L2 DNA-binding function. A summary of L2-DNA interaction results is given in Fig. 4 .
L2-DNA interaction has no DNA sequence specificity. We used a library of oligonucleotides and bound these to purified HPV16L2 protein to select for any high-affinity target DNA sequences. The oligonucleotides were random at 26 positions and were flanked by primer and cloning sequences. After incubation of L2 with a pool of these oligonucleotides, oligonucleotides bound to L2 protein were eluted and amplified by PCR for subsequent rounds of selection. Selection and amplification were carried out six times. DNA clones recovered after the selection rounds 5 and 6 were sequenced. Probability theory predicts that among 52 random 26-mer sequences, any trinucleotide would be found in 20 clones (95% confidence interval, 15 to 26) and any specificed sequence of 4 nucleotides would be found in 5 of the 26-mers (95% confidence interval, 0 to 9). Among 52 26-mer clones we observed that the most commonly observed trinucleotide (GGG) was present in 24 clones (twice in 5, three times in 1), whereas the most common series of 4 bp (GGGG) was observed in 8 clones. Thus there was no evidence that any short nucleotide sequence was represented among these clones more frequently than would be expected by chance alone. Further, no more complex conserved nucleotide patterns were observed by using standard sequence alignment programs. These results suggested that high-affinity binding between L2 and DNA is a DNA sequenceindependent process. Two additional experiments confirmed this observation. First, extract from cells infected with DNA binding
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HPV16L2 rVV was immunoprecipitated with anti-L2 antibody, and the precipitated protein-antibody complexes, attached to Sepharose beads, were allowed to bind to a mixture of restriction fragments from HPV16 genomic DNA. After unbound DNA was washed away, bound DNA fragments were resolved on a agarose gel and detected by Southern blotting with 32P-labeled HPV16 DNA. An HPV16L2-containing extract, bound to Sepharose beads with anti-L2 antibody, retained each of the HPV16 DNA fragments (Fig. 5, lanes 3, 6 , and 7), whereas none of these fragments were bound by an Li rVV-infected cell extract bound to the bead with anti-Li antibody (data not shown) or by wild-type VV-infected cell extract bound to the beads with L2-specific antibodies (Fig. 5,  lane 22 . Second, a fixed amount of L2 protein was incubated with 3 P-labeled HPV DNA fragments, in the presence of a 100-fold (lane 4) or 1,000-fold (lane 5) excess of unlabeled X DNA, and L2, together with any bound DNA, was immunoprecipitated from the mixture by antibody to L2. Phage K DNA was able to prevent binding of HPV DNA. We conclude that L2 does not interact with DNA in a DNA sequence-specific manner by each of these criteria.
DISCUSSION
The predicted sequence of the carboxy terminus of the Li and L2 proteins of all sequenced PVs includes several basic amino acids. We demonstrated that the carboxy terminus of the Li protein of HPV16, which conforms to consensus nuclear localization sequences defined for eukaryotic cells, is necessary for nuclear localization of this protein (36) . A basic sequence is also found at the amino terminus of L2, but this does not conform to the nuclear localization sequence motif and resembles the arginine-rich region which has been associated with protein-RNA binding (19) . An arginine-rich motif sequence has previously been detected in several prokaryotic and eukaryotic RNA-binding proteins (19, 20) , and the VP1 J. VIROL. (8) .
Our results suggest that DNA binding to L2 requires multiple basic amino acid sequences working in concert, while the amino acids separating the basic residues also contribute to DNA-binding activity. Similarities between the amino-terminal sequences of PV L2 proteins were identified in searches of the GenBank and EMBL data bases. The basic residues (Arg and/or Lys) are in each case located proximally in the aminoterminal sequence of L2, and their side chains could be positioned so that their positive charges interact with the backbone phosphates of the DNA helix.
To study the intrinsic DNA-binding activity of LI and L2 proteins, it was necessary to exclude the contribution of cellular proteins to this reaction. We therefore examined binding of HPV DNA, produced in a prokaryotic system, to viral proteins isolated by immunoprecipitation and separated by SDS-PAGE for Southwestern analysis, because this avoided exposure of the HPV DNA to cellular proteins including histones. HPV16L2 protein associated with DNA under our assay conditions, whereas HPV16L1 protein did not. This latter observation is in contrast with previous work (22) , which showed that prokaryotic L2 bound DNA and also that a prokaryotic N-terminally truncated LI fusion protein, with 37% of the sequence from the N terminus removed, had DNA-binding activity. The LI or L2 protein of HPV16 produced by VV are nonfused proteins which should have correct posttranslational modifications, including glycosylation (38) and phosphorylation (35) , which could affect DNA-binding affinity (21, 32) . Because the LI protein we used in this study was a nonfusion protein expressed in eukaryotic cells, we believe that this protein should have correct posttranslational modifications. Further, the binding demonstrated in this assay occurred under physiologic conditions of pH and salt concentration. Thus, our LI-DNA-binding results are more likely to be representative of events within epithelial cells infected with HPV. However, the Southwestern assay system depends on prior immobilization of the test viral protein to positively charged nitrocellulose while the protein is denatured in SDS, and this would favor the demonstration of amino-or carboxyterminal regions as DNA binding, so we cannot regard Ll-DNA interactions under physiological conditions as excluded by our results.
We have previously shown that the minor capsid protein (L2) of HPV16 plays a role in the assembly of infectious PV virions: whereas viruslike particles assemble if LI protein alone is expressed in eukaryotic cells (17) , expression of both LI and L2 together are necessary for the assembly of infectious virions (37) , at least when the proteins are expressed by rVV in vitro. The findings reported here suggest that one role of L2 in the assembly of infectious PV virions may be to link the PV capsid to the viral minichromosome, a function made necessary by a lack of demonstrable interaction of HPV LI protein with HPV DNA. Since one purpose of any virus capsid is to provide a protective container for the viral genome, capsid proteins are expected to exhibit some potential for direct (basic or other polar amino acid side chains) or indirect (encapsidated polyamines) interaction with nucleic acid (5) . This interaction may be important in nucleation of capsid assembly but could also serve a structural purpose in defining the viral architecture for DNA viruses, as is now well recognized for RNA viruses, many of which will assemble virions only in the presence of appropriate viral RNA (2, 5, 25) .
Studies of RNA viruses have shown that specific encapsidation initiation sites are present on the viral genome (3) . Such sites have also been identified for DNA viruses (27, 30) . Our data do not support the hypothesis that packaging selectivity in PV could be achieved by sequence-specific recognition process between viral structural proteins and PV DNA. Lack of specific reactivity also makes a role for the L2-DNA interaction in regulation of transcription, replication, recombination, or viral integration less likely. This finding is perhaps not too surprising, because the expression of capsid proteins occurs in terminally differentiated cells already programmed to undergo apoptotic death.
A model has been proposed for the structure of polyomavirus, which has an identical T=7d icosahedral structure to PV (14) . Polyomavirus VP1 protein, which has sequence homology with HPVL1 and will similarly self-assemble into viruslike particles, can (8) . Our data, taken together with this model, suggest that the amino terminus of L2 will be located deep within the viral particle in contact with the viral minichromosome, which is supercoiled round cellular histone proteins. The viral minichromosome will be held in place by an array of L2 proteins, each interacting via its amino terminus with any convenient stretch of viral DNA and, at a more carboxy location, with a pentameric Li capsomere. In the terminally differentiating PV-infected keratinocyte, HPV DNA would be one of the most abundant short polynucleotides and nuclear DNA would generally be present in the form of condensed cellular chromatin (23) . No specific protein-DNA interaction may therefore be required for PV particle assembly. Alternatively, Li protein (36a) appear to localize in particular areas of the cell nucleus in the presence of L2 protein, at least in vitro. If some mechanism exists for local concentration of Li, L2, and viral DNA, correct viral assembly would follow. Use of L2 deletion mutants as described here should facilitate testing of these alternate hypotheses.
